Changing the Culture of the FDA Act

Bill: 116-s-417
Sponsor: full_name: Sen. Manchin, Joe, III [D-WV]
Introduced: 2019-02-07
Policy area: Health
Subjects: Department of Health and Human Services

Drug safety, medical device, and laboratory regulation

Drug trafficking and controlled substances

Food and Drug Administration (FDA)

Prescription drugs
Latest action: action_date: 2019-02-07
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2019-02-07
action_desc: Introduced in Senate
text: <p><b>Changing the Culture of the FDA Act</b></p> This bill requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)

tv_txt: II 116th CONGRESS 1st Session S. 417 IN THE SENATE OF THE UNITED STATES February 7, 2019 Mr. Manchin introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.

1. Short title This Act may be cited as the Changing the Culture of the FDA Act . 2. Mission Statement of the Food and Drug Administration The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall amend the mission statement of the Food and Drug Administration to include the following statement: The FDA is also responsible for protecting the public health by strongly considering the danger of addiction and overdose death associated with prescription opioid medications when approving these medications and when regulating the manufacturing, marketing, and distribution of opioid medications. .